Researchers have developed a new computational method that increases the ability to track the spread of cancer cells from one part of the body to another. This migration of cells can lead to metastatic disease, which causes about 90 percent of cancer deaths from solid tumors -- masses of cells that grow in organs such as the breast, prostate or colon. Understanding the drivers of metastasis could lead to new treatments aimed at blocking the process of cancer spreading through the body.
OPKO Health (Nasdaq: OPK) and Pfizer (NYSE: PFE) Announce Positive Phase 3 Top-Line Results for Somatrogon, an Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency
**Disclaimer: Crown Equity Holdings Inc. has received $5,000.00 (five thousand dollars) in cash from Nass Valley Gateway Ltd. (CSE:NVG) (FSE:3NVN) for 30 days of advertisement services